Below are the earnings highlights for Alnylam Pharmaceuticals Inc. (ALNY):
Earnings: -$83.76 million in Q4 vs. -$137.87 million in the same period last year.
EPS: -$0.65 in Q4 vs. -$1.10 in the same period last year.
Excluding items, Alnylam Pharmaceuticals Inc. reported adjusted earnings of $8.05 million or $0.06 per share for the period.
Analysts projected -$0.14 per share
Revenue: $593.17 million in Q4 vs. $439.72 million in the same period last year.
For comments and feedback: editorial@rttnews.com